An effort to examine the feasibility of whole exome and transcriptome sequencing in guiding personalized therapy for patients with non-small cell lung cancer
Journal of Clinical Oncology, 2017.
e19136 Background: Usefulness of the next-generation sequencing in clinical practice for cancer treatment is in early development. We sought to evaluate the feasibility of clinical application of whole exome sequencing (WES) or whole exome plus transcriptome sequencing (WETS) to provide guidance for personalized therapy. Methods: Tumor sa...More
Full Text (Upload PDF)